Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3

Hormone and Metabolic Research

Volumn 45, Issue 3, 2013, Pages 213-220

  Zhu, X ^a   Walton, R G ^b   Tian, L ^a   Luo, N ^b   Ho, S R ^a   Fu, Y ^b   Garvey, W T ^b,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

C2C12 cells; glucose transport; insulin sensitivity; MINOR; NR4A3; prostaglandin A2; skeletal muscle

Indexed keywords

GLUCOSE; INSULIN; NUCLEAR RECEPTOR NR4A3; PROSTAGLANDIN A2; PROTEIN KINASE B; SHORT HAIRPIN RNA; PROSTAGLANDIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; INSULIN SENSITIVITY; LENTIVIRINAE; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ANIMAL; CELL DIFFERENTIATION; CELL STRAIN HEK293; CYTOLOGY; DRUG EFFECT; GENE SILENCING; GENETIC TRANSDUCTION; HUMAN; INSULIN RESISTANCE; METABOLISM; TIME;

ANIMALS; CELL DIFFERENTIATION; GENE SILENCING; HEK293 CELLS; HUMANS; INSULIN; INSULIN RESISTANCE; LENTIVIRUS; MICE; MUSCLE CELLS; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 3; PROSTAGLANDINS A; TIME FACTORS; TRANSDUCTION, GENETIC;

EID: 84875222483     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1327619     Document Type: Article

References (29)

1. Wilson T. E., Fahrner T. J., Johnston M., Milbrand J. Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science: 1991; 252 1296 1300 (Pubitemid 21917041)
2. Davis I. J., Lau L. F. Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands. Mol Cell Biol: 1994; 14 3469 3483 (Pubitemid 24132757)
3. Borghaei R. C., Rawlings P. L. Jr, Mochan E. Interleukin-4 suppression of interleukin-1-induced transcription of collagenase (MMP-1) and stromelysin 1 (MMP-3) in human synovial fibroblasts. Arthritis Rheum: 1998; 41 1398 1406 (Pubitemid 28373118)
4. Kagaya S., Ohkura N., Tsukada T., Miyagawa M., Sugita Y., Tsujimoto G., Matsumoto K., Saito H., Hashida R. Prostaglandin A2 acts as a transactivator for NOR1 (NR4A3) within the nuclear receptor superfamily. Biol Pharm Bull: 2005; 28 1603 1607 (Pubitemid 41324116)
5. Hazel T. G., Nathans D., Lau L. F. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily. Proc Natl Acad Sci USA: 1988; 85 8444 8448 (Pubitemid 19024988)
6. Le W. D., Xu P., Jankovic J., Jiang H., Appel S. H., Smith R. G., Vassilatis D. K. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet: 2003; 33 85 89 (Pubitemid 36068688)
7. Pei L., Castrillo A., Tontonoz P. Regulation of macrophage inflammatory gene expression by the orphan nuclear receptor Nur77. Mol Endocrinol: 2006; 20 786 794
8. Rius J., Martinez-Gonzalez J., Crespo J., Badimon L. NOR-1 is involved in VEGF-induced endothelial cell growth. Atherosclerosis: 2006; 184 276 282 (Pubitemid 43049710)
9. Ohkubo T., Ohkura N., Maruyama K., Sasaki K., Nagasaki K., Hanzawa H., Tsukada T., Yamaguchi K. Early induction of the orphan nuclear receptor NOR-1 during cell death of the human breast cancer cell line MCF-7. Mol Cell Endocrinol: 2000; 162 151 156 (Pubitemid 30347458)
10. Oita R. C., Mazzatti D. J., Lim F. L., Powell J. R., Merry B. J. Whole-genome microarray analysis identifies up-regulation of Nr4a nuclear receptors in muscle and liver from diet-restricted rats. Mech Ageing Dev: 2009; 130 240 247
11. Fontana L., Klein S., Holloszy J. O. Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr): 2010; 32 97 108
12. Chao L. C., Wroblewski K., Zhang Z., Pei L., Vergnes L., Ilkayeva O. R., Ding S. Y., Reue K., Watt M. J., Newgard C. B., Pilch P. F., Hevener A. L., Tontonoz P. Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77. Diabetes: 2009; 58 2788 2796
13. Fu Y., Luo L., Luo N., Zhu X., Garvey T. NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem: 2007; 282 31525 31533 (Pubitemid 350044839)
14. Straus D. S., Glass C. K. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev: 2001; 21 185 210 (Pubitemid 32303994)
15. Mayor P., Maianu L., Garvey W. T. Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes. Effects on glucose transporter gene expression. Diabetes: 1992; 41 274 285
16. Nedachi T., Kanzaki M. Regulation of glucose transporters by insulin and extracellular glucose in C2C12 myotubes. Am J Physiol Endocrinol Metab: 2006; 291 E817 E828 (Pubitemid 44484925)
17. Pei L., Waki H., Vaitheesvaran B., Wilpitz D. C., Kurland I. J., Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med: 2006; 12 1048 1055 (Pubitemid 44353386)
18. Chao L. C., Zhang Z., Pei L., Saito T., Tontonoz P., Pilch P. F. Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. Mol Endocrinol: 2007; 21 2152 2163 (Pubitemid 47347379)
19. Kim E. H., Surh Y. J. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol: 2006; 72 1516 1528
20. Kim H. J., Kim J. Y., Meng Z., Wang L. H., Liu F., Conrads T. P., Burke T. R., Veenstra T. D., Farrar W. L. 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain. Cancer Res: 2007; 67 2595 2602 (Pubitemid 46548945)
21. Milne G. L., Musiek E. S., Morrow J. D. The cyclopentenone (A2/J2) isoprostanes - unique, highly reactive products of arachidonate peroxidation. Antioxid Redox Signal: 2005; 7 210 220 (Pubitemid 40187938)
22. Oh J. Y., Giles N., Landar A., Darley-Usmar V. Accumulation of 15-deoxy-delta(12,14)-prostaglandin J2 adduct formation with Keap1 over time: effects on potency for intracellular antioxidant defence induction. Biochem J: 2008; 411 297 306 (Pubitemid 351580182)
23. Levonen A. L., Dickinson D. A., Moellering D. R., Mulcahy R. T., Forman H. J., Darley-Usmar V. M. Biphasic effects of 15-deoxy-delta-(12,14)- prostaglandin J(2) on glutathione induction and apoptosis in human endothelial cells. Arterioscler Thromb Vasc Biol: 2001; 21 1846 1851 (Pubitemid 34219791)
24. Landar A., Zmijewski J. W., Dickinson D. A., Le Goffe C., Johnson M. S., Milne G. L., Zanoni G., Vidari G., Morrow J. D., Darley-Usmar V. M. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am J Physiol Heart Circ Physiol: 2006; 290 H1777 H1787
25. Fukushima M., Kato T., Ota K., Arai Y., Narumiya S., Hayaishi O. 9-deoxy-delta 9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities. Biochem Biophys Res Commun: 1982; 109 626 633 (Pubitemid 13143731)
26. Fitzpatrick F. A., Wynalda M. A. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. J Biol Chem: 1983; 258 11713 11718
27. Forman B. M., Tontonoz P., Chen J., Brun R. P., Spiegelman B. M., Evans R. M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell: 1995; 83 803 812 (Pubitemid 3006324)
28. Kliewer S. A., Lenhard J. M., Willson T. M., Patel I., Morris D. C., Lehmann J. M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell: 1995; 83 813 819 (Pubitemid 3006325)
29. Tortorella L. L., Pilch P. F. C2C12 myocytes lack an insulin-responsive vesicular compartment despite dexamethasone-induced GLUT4 expression. Am J Physiol Endocrinol Metab: 2002; 283 E514 E524 (Pubitemid 35230489)